Align Technology Inc (ALGN)
NASDAQ · Healthcare · Medical Instruments & Supplies
Align Technology Inc is a Healthcare company with a market capitalization of $12.78B and a trailing P/E ratio of 30.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $2.58 | $2.29 | +12.7% |
| Q4 2025 | February 4, 2026 | $3.29 | $2.97 | +10.8% |
| Q3 2025 | October 29, 2025 | $2.61 | $2.41 | +8.3% |
| Q2 2025 | July 30, 2025 | $2.49 | $2.57 | -3.1% |
| Q1 2025 | April 30, 2025 | $2.13 | $1.99 | +7.1% |
| Q4 2024 | February 5, 2025 | $2.44 | $2.45 | -0.4% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is Align Technology Inc's market cap?
As of June 29, 2026, Align Technology Inc (ALGN) has a market capitalization of $12.78B.
What is Align Technology Inc's P/E ratio?
Align Technology Inc trades at a trailing price-to-earnings (P/E) ratio of 30.0. Its forward P/E is 15.7.
Does Align Technology Inc pay a dividend?
Align Technology Inc does not currently pay a dividend.
What sector is ALGN in?
Align Technology Inc is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was Align Technology Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Align Technology Inc reported revenue of $4.03B and net income of $410.35M.
Ask your own questions about ALGN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.